Page last updated: 2024-12-06

tetrabutoxy titanium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tetrabutoxy titanium: RN given refers to monomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21801
MeSH IDM0167260

Synonyms (50)

Synonym
butyl alcohol, titanium(4+) salt
butyl titanate(iv), (buo)4ti
titanium tetrabutoxide
tyzor tbt
butyl titanate(iv)
titanium, tetrabutoxy-
titanic acid, tetrabutyl ester
butyl orthotitanate
titanium tetrabutylate
nsc-59799
tyzor bp
1-butanol, titanium(4+) salt
tetrabutyl titanate
titanium butoxide (ti(obu)4)
titanium(iv) n-butoxide
tetrabutyl orthotitanate
5593-70-4
nsc-220232
hsdb 839
orgatics ta 25
butyl titanate monomer
butyl titanate
titanium(4+) butoxide
titanium tetrakis(butoxide)
nsc 59799
einecs 227-006-8
orthotitanic acid, tetrabutyl ester
titanium butylate
tetrabutoxy titanium
titanium tetrabutanolate
tetrabutyltitanate [czech]
1-butanol titanium(4+) salt
b 1 (titanate)
nsc 220232
titanium butoxide
tetrabutoxy titan
B0742
9022-96-2
fjs8q2mx9i ,
unii-fjs8q2mx9i
ec 227-006-8
1-butanol, titanium(4+) salt (4:1)
tetrabutoxy titanium [hsdb]
AKOS025243244
DTXSID6041262
orthotitanic acid tetrabutylester
FT-0699968
Q4456610
4-(2,5-dimethyl-1h-pyrrol-3-yl)pyridine
butan-1-olate;titanium(4+)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.21 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]